|View printer-friendly version|
|Array BioPharma to Report Financial Results for the Fourth Quarter And Full Year of Fiscal 2001 on August 6, 2001|
BOULDER, Colo., July 31 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the fourth quarter and full year of fiscal 2001 on Monday, August 6, 2001, at 4:30 p.m. eastern time and hold a conference call on Tuesday, August 7, 2001, at 9:00 a.m. eastern time. Robert E. Conway, Chief Executive Officer, and R. Michael Carruthers, Chief Financial Officer, will lead the call.
CONFERENCE CALL INFORMATION
Web Cast: www.arraybiopharma.com
There will be a replay of the conference call for one week, which can be accessed by dialing toll-free (888) 203-1112, and outside the US (719) 457-0820. The access code is 436848. Replay of the call will also be available as a web cast on Array's web site at www.arraybiopharma.com.
Array BioPharma is a drug discovery company creating new drugs through innovations in chemistry and structural biology. Array's world-class scientific team integrates chemistry and structural biology with an information-based technology platform to create higher quality drug candidates. Array provides drug discovery expertise to collaborators and for its own proprietary research.
For more information on Array BioPharma, please visit the company's web site at www.arraybiopharma.com.
MAKE YOUR OPINION COUNT - Click Here http://tbutton.prnewswire.com/prn/11690X57460183
SOURCE Array BioPharma Inc.
CONTACT: Tricia Haugeto of Array BioPharma Inc., +1-303-386-1193, firstname.lastname@example.org/